RSS

Principia Biopharma

Brain cancer vaccine awarded orphan status by FDA

Sanofi and Principia Biopharma have entered into an agreement to develop a clinical-stage oral drug candidate as a potential therapy for multiple sclerosis (MS) and other central nervous system (CNS) diseases. Read more

News